120 related articles for article (PubMed ID: 2660984)
1. Targeting of methotrexate-containing liposomes with a monoclonal antibody against human renal cancer.
Singh M; Ghose T; Faulkner G; Kralovec J; Mezei M
Cancer Res; 1989 Jul; 49(14):3976-84. PubMed ID: 2660984
[TBL] [Abstract][Full Text] [Related]
2. Antibody directed targeting of methotrexate-containing small unilamellar vesicles.
Singh M; Faulkner G; Ghose TI; Mezei M
Cancer Immunol Immunother; 1988; 27(1):17-25. PubMed ID: 3293779
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human renal cancer by monoclonal antibody targeted methotrexate-containing liposomes in an ascites tumor model.
Singh M; Ghose T; Mezei M; Belitsky P
Cancer Lett; 1991 Feb; 56(2):97-102. PubMed ID: 1998948
[TBL] [Abstract][Full Text] [Related]
4. Uptake of methotrexate linked to polyclonal and monoclonal antimelanoma antibodies by a human melanoma cell line.
Uadia P; Blair AH; Ghose T; Ferrone S
J Natl Cancer Inst; 1985 Jan; 74(1):29-35. PubMed ID: 3855485
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to kidney and tumor-associated surface antigens of human renal cell carcinoma.
Luner SJ; Ghose T; Chatterjee S; Cruz HN; Belitsky P
Cancer Res; 1986 Nov; 46(11):5816-20. PubMed ID: 3530441
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human renal cancer by methotrexate linked to a monoclonal antibody.
Singh M; Kralovec J; Mezei M; Ghose T
J Urol; 1989 Feb; 141(2):428-31. PubMed ID: 2643730
[TBL] [Abstract][Full Text] [Related]
7. Effect of methotrexate-monoclonal anti-prostatic acid phosphatase antibody conjugate on human prostate tumor.
Deguchi T; Chu TM; Leong SS; Horoszewicz JS; Lee CL
Cancer Res; 1986 Aug; 46(8):3751-5. PubMed ID: 3731053
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunotherapy of human B-cell chronic lymphocytic leukemia in nude mice.
Zhu Z; Ghose T; Hoskin D; Lee CL; Fernandez LA; Lee SH; Mammen M
Cancer Res; 1994 Oct; 54(19):5111-7. PubMed ID: 7923127
[TBL] [Abstract][Full Text] [Related]
9. Specific enhancement of drug delivery to AKR lymphoma by antibody-targeted small unilamellar vesicles.
Matthay KK; Heath TD; Papahadjopoulos D
Cancer Res; 1984 May; 44(5):1880-6. PubMed ID: 6713389
[TBL] [Abstract][Full Text] [Related]
10. Regression of human melanoma xenografts in nude mice injected with methotrexate linked to monoclonal antibody 225.28 to human high molecular weight-melanoma associated antigen.
Ghose T; Ferrone S; Blair AH; Kralovec Y; Temponi M; Singh M; Mammen M
Cancer Immunol Immunother; 1991; 34(2):90-6. PubMed ID: 1760821
[TBL] [Abstract][Full Text] [Related]
11. Targeting, internalization, and cytotoxicity of methotrexate-monoclonal anti-stage-specific embryonic antigen-1 antibody conjugates in cultured F-9 teratocarcinoma cells.
Shen WC; Ballou B; Ryser HJ; Hakala TR
Cancer Res; 1986 Aug; 46(8):3912-6. PubMed ID: 2873883
[TBL] [Abstract][Full Text] [Related]
12. Nature of linkage and mode of action of methotrexate conjugated with antitumor antibodies: implications for future preparation of conjugates.
Endo N; Takeda Y; Umemoto N; Kishida K; Watanabe K; Saito M; Kato Y; Hara T
Cancer Res; 1988 Jun; 48(12):3330-5. PubMed ID: 3259466
[TBL] [Abstract][Full Text] [Related]
13. [Specific in vitro effects of methotrexate entrapped into liposomes bearing antibody fragments against human chorionic gonadotropin on cell growth of cultured human choriocarcinoma cells].
Mano H; Hattori S; Furuhashi Y; Goto S; Tomoda Y; Naoi M
Gan To Kagaku Ryoho; 1984 Sep; 11(9):1775-80. PubMed ID: 6541022
[TBL] [Abstract][Full Text] [Related]
14. Endocytosis and de novo expression of major histocompatibility complex encoded class I molecules: kinetic and ultrastructural studies.
Machy P; Truneh A; Gennaro D; Hoffstein S
Eur J Cell Biol; 1987 Dec; 45(1):126-36. PubMed ID: 3443107
[TBL] [Abstract][Full Text] [Related]
15. Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductase.
Jolivet J; Chabner BA
J Clin Invest; 1983 Sep; 72(3):773-8. PubMed ID: 6193143
[TBL] [Abstract][Full Text] [Related]
16. Studies of methotrexate-monoclonal antibody conjugates for immunotherapy.
Kanellos J; Pietersz GA; McKenzie IF
J Natl Cancer Inst; 1985 Aug; 75(2):319-32. PubMed ID: 2991647
[TBL] [Abstract][Full Text] [Related]
17. Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody.
Mizutani Y; Bonavida B; Koishihara Y; Akamatsu K; Ohsugi Y; Yoshida O
Cancer Res; 1995 Feb; 55(3):590-6. PubMed ID: 7834629
[TBL] [Abstract][Full Text] [Related]
18. Role of ligand in antibody-directed endocytosis of liposomes by human T-leukemia cells.
Matthay KK; Abai AM; Cobb S; Hong K; Papahadjopoulos D; Straubinger RM
Cancer Res; 1989 Sep; 49(17):4879-86. PubMed ID: 2788031
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human renal cancer by monoclonal-anti-body-linked methotrexate in an ascites tumor model.
Singh M; Ghose T; Kralovec J; Blair AH; Belitsky P
Cancer Immunol Immunother; 1991; 32(5):331-4. PubMed ID: 1998974
[TBL] [Abstract][Full Text] [Related]
20. Antibody-directed liposomes: comparison of various ligands for association, endocytosis, and drug delivery.
Matthay KK; Heath TD; Badger CC; Bernstein ID; Papahadjopoulos D
Cancer Res; 1986 Oct; 46(10):4904-10. PubMed ID: 3756852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
